Aprepitant and Intestinal volvulus - from FDA reports


Summary

Intestinal volvulus is found among people who take Aprepitant, especially for people who are female, 60+ old , have been taking the drug for < 1 month, also take medication Dexamethasone, and have Preventive health care. This review analyzes which people have Intestinal volvulus with Aprepitant. It is created by eHealthMe based on reports of 1,879 people who have side effects when taking Aprepitant from FDA , and is updated regularly.

What to expect?

If you take Aprepitant and have Intestinal volvulus, find out what symptoms you could have in 1 year or longer.

You are not alone!

Join a support group for people who take Aprepitant and have Intestinal volvulus

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

On Jan, 15, 2018

1,879 people reported to have side effects when taking Aprepitant.
Among them, 24 people (1.28%) have Intestinal volvulus


Number of reports submitted per year:

Could Aprepitant cause Intestinal volvulus?

Time on Aprepitant when people have Intestinal volvulus *:

  • < 1 month: 85.71 %
  • 1 - 6 months: 14.29 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Intestinal volvulus when taking Aprepitant *:

  • female: 54.17 %
  • male: 45.83 %

Age of people who have Intestinal volvulus when taking Aprepitant *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 8.7 %
  • 40-49: 4.35 %
  • 50-59: 26.09 %
  • 60+: 60.87 %

Top conditions involved for these people *:

  • Preventive Health Care (6 people, 25.00%)
  • Pancreatic Carcinoma Metastatic (5 people, 20.83%)
  • Hodgkin's Lymphoma (4 people, 16.67%)
  • Lung Cancer - Non-Small Cell (3 people, 12.50%)
  • Cough (3 people, 12.50%)

Top co-used drugs for these people *:

  • Palonosetron (9 people, 37.50%)
  • Dexamethasone (9 people, 37.50%)
  • Cisplatin (8 people, 33.33%)
  • Ondansetron (7 people, 29.17%)
  • Ibuprofen (7 people, 29.17%)

Top other side effects for these people *:

  • Nausea And Vomiting (9 people, 37.50%)
  • Dehydration (9 people, 37.50%)
  • Agranulocytosis (7 people, 29.17%)
  • White Blood Cell Count Decreased (6 people, 25.00%)
  • Ascites (6 people, 25.00%)

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

Want to find out more about the FDA reports used in the study? You can request them from FDA.

Do you have Intestinal volvulus when taking Aprepitant?

Expand the study to include all drugs with the same ingredients

Intestinal volvulus and drugs with ingredients of aprepitant.

Expand the study to include reports from both FDA and eHealthMe

Intestinal volvulus and Aprepitant from FDA and eHealthMe reports

Aprepitant

Aprepitant has active ingredients of aprepitant. (latest outcomes from Aprepitant 1,882 users)

Intestinal volvulus

Intestinal volvulus (complete twisting of a loop of intestine around its mesenteric attachment site) has been reported by people with crohn's disease, acne, high blood pressure, pain (latest reports from 28,514 Intestinal volvulus patients).

Browse all side effects of Aprepitant

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Intestinal volvulus

Intestinal volvulus

Could your condition cause Intestinal volvulus

Intestinal volvulus

Related studies

What would happen?

Forecast new side effects and undetected conditions when you take Aprepitant and have Intestinal volvulus.

Questions to the study

More questions >

User posts to the study

More posts >